241 related articles for article (PubMed ID: 22444671)
1. Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.
Ng BG; Hackmann K; Jones MA; Eroshkin AM; He P; Wiliams R; Bhide S; Cantagrel V; Gleeson JG; Paller AS; Schnur RE; Tinschert S; Zunich J; Hegde MR; Freeze HH
Am J Hum Genet; 2012 Apr; 90(4):685-8. PubMed ID: 22444671
[TBL] [Abstract][Full Text] [Related]
2. Congenital diaphragmatic hernia and early lethality in PIGL-related disorder.
Winter-Paquette LM; Al Suwaidi HH; Sajjad Y; Bricker L
Eur J Med Genet; 2022 May; 65(5):104501. PubMed ID: 35378319
[TBL] [Abstract][Full Text] [Related]
3. Alu-mediated deletion of PIGL in a Patient with CHIME syndrome.
Knight Johnson A; Schaefer GB; Lee J; Hu Y; Del Gaudio D
Am J Med Genet A; 2017 May; 173(5):1378-1382. PubMed ID: 28371479
[TBL] [Abstract][Full Text] [Related]
4. Child with a mild CHIME syndrome phenotype and carrying a novel p.(Asp52Asn) PIGL pathogenic variant in association with the previously reported p.(Leu167Pro) variant: A case report.
Rolland M; Dubourg C; Cospain A; Droitcourt C; Pasquier L
Pediatr Dermatol; 2022 May; 39(3):434-437. PubMed ID: 35258128
[TBL] [Abstract][Full Text] [Related]
5. Mutations in PIGL in a patient with Mabry syndrome.
Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
[TBL] [Abstract][Full Text] [Related]
6. Severe congenital ichthyosiform dermatosis in CHIME syndrome successfully treated with ixekizumab.
Flowers LE; Dyer JA; Eisenstein KA
Pediatr Dermatol; 2024 May; ():. PubMed ID: 38773877
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphatasia with mental retardation syndrome, expanded phenotype of
Altassan R; Fox S; Poulin C; Buhas D
Mol Genet Metab Rep; 2018 Jun; 15():46-49. PubMed ID: 30023290
[TBL] [Abstract][Full Text] [Related]
8. Neuroectodermal (CHIME) syndrome: an additional case with long term follow up of all reported cases.
Shashi V; Zunich J; Kelly TE; Fryburg JS
J Med Genet; 1995 Jun; 32(6):465-9. PubMed ID: 7666399
[TBL] [Abstract][Full Text] [Related]
9. The Glycosylphosphatidylinositol biosynthesis pathway in human diseases.
Wu T; Yin F; Guang S; He F; Yang L; Peng J
Orphanet J Rare Dis; 2020 May; 15(1):129. PubMed ID: 32466763
[TBL] [Abstract][Full Text] [Related]
10. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin.
Brodsky RA; Mukhina GL; Li S; Nelson KL; Chiurazzi PL; Buckley JT; Borowitz MJ
Am J Clin Pathol; 2000 Sep; 114(3):459-66. PubMed ID: 10989647
[TBL] [Abstract][Full Text] [Related]
11. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
[TBL] [Abstract][Full Text] [Related]
12. Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability.
Hansen L; Tawamie H; Murakami Y; Mang Y; ur Rehman S; Buchert R; Schaffer S; Muhammad S; Bak M; Nöthen MM; Bennett EP; Maeda Y; Aigner M; Reis A; Kinoshita T; Tommerup N; Baig SM; Abou Jamra R
Am J Hum Genet; 2013 Apr; 92(4):575-83. PubMed ID: 23561846
[TBL] [Abstract][Full Text] [Related]
13. What syndrome is this? CHIME syndrome.
Sidbury R; Paller AS
Pediatr Dermatol; 2001; 18(3):252-4. PubMed ID: 11438011
[No Abstract] [Full Text] [Related]
14. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin.
Diep DB; Nelson KL; Raja SM; Pleshak EN; Buckley JT
J Biol Chem; 1998 Jan; 273(4):2355-60. PubMed ID: 9442081
[TBL] [Abstract][Full Text] [Related]
15. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia.
Mukhina GL; Buckley JT; Barber JP; Jones RJ; Brodsky RA
Br J Haematol; 2001 Nov; 115(2):476-82. PubMed ID: 11703352
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia in a child with the CHIME neuroectodermal dysplasia syndrome.
Schnur RE; Greenbaum BH; Heymann WR; Christensen K; Buck AS; Reid CS
Am J Med Genet; 1997 Oct; 72(1):24-9. PubMed ID: 9295069
[TBL] [Abstract][Full Text] [Related]
17. A novel PIGN mutation and prenatal diagnosis of inherited glycosylphosphatidylinositol deficiency.
Nakagawa T; Taniguchi-Ikeda M; Murakami Y; Nakamura S; Motooka D; Emoto T; Satake W; Nishiyama M; Toyoshima D; Morisada N; Takada S; Tairaku S; Okamoto N; Morioka I; Kurahashi H; Toda T; Kinoshita T; Iijima K
Am J Med Genet A; 2016 Jan; 170A(1):183-8. PubMed ID: 26419326
[TBL] [Abstract][Full Text] [Related]
18. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin.
Brodsky RA; Mukhina GL; Nelson KL; Lawrence TS; Jones RJ; Buckley JT
Blood; 1999 Mar; 93(5):1749-56. PubMed ID: 10029605
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
20. Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN.
Maydan G; Noyman I; Har-Zahav A; Neriah ZB; Pasmanik-Chor M; Yeheskel A; Albin-Kaplanski A; Maya I; Magal N; Birk E; Simon AJ; Halevy A; Rechavi G; Shohat M; Straussberg R; Basel-Vanagaite L
J Med Genet; 2011 Jun; 48(6):383-9. PubMed ID: 21493957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
